M9W-28565-73957 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2023-02-10
Registered in v-safe
2023-02-10
Dose 1 — Pfizer-BioNTech
Co-administered: Flu:Hib:Pneumonia:Polio:Rotavirus:Tetanus
2023-02-10
Health check-in — day 0, dose 1, under 3
Feeling: Good · Site: Pain · Sleepiness · Be unable to work or attend school

Under 3 check-in
2023-02-11
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Site: Pain, Redness, Swelling/hardness · Fever · Diarrhea

Under 3 check-in
2023-02-12
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Pain, Redness · None

Under 3 check-in
2023-02-13
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Pain, Redness · None

Under 3 check-in
2023-02-14
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2023-02-15
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2023-02-16
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Rhinorrhoea — Feeling: Good

MedDRA releases: 2024-11
2023-02-17
Survey response — day 7, dose 1, under 3
MedDRA: Rhinorrhoea — Feeling: Good

MedDRA releases: 2024-11
2023-02-27
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-03-03
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-03-10
Dose 2 — Pfizer-BioNTech
Co-administered: Flu
2023-03-10
Survey response — day 0, dose 2, under 3
MedDRA: Eye discharge, Nasal congestion — Feeling: Fair · Site: Pain · Irritability/crying

MedDRA releases: 2024-11
2023-03-11
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Eye discharge, Nasal congestion — Feeling: Fair · Site: Pain

MedDRA releases: 2024-11
2023-03-12
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Eye discharge, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-03-13
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Eye discharge, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-03-14
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Eye discharge, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-03-15
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Eye discharge, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-03-16
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-03-17
Survey response — day 7, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-03-24
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-03-31
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-04-07
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-04-14
Survey response — day 35, dose 2, under 3
MedDRA: Rhinorrhoea — Feeling: Good

MedDRA releases: 2024-11
2023-04-21
Survey response — day 42, dose 2, under 3
MedDRA: Cough — Feeling: Fair

MedDRA releases: 2024-11
2023-05-12
Dose 3 — Pfizer-BioNTech
2023-05-12
Health check-in — day 0, dose 3, under 3
Feeling: Good · Site: Pain · Irritability/crying

Under 3 check-in
2023-05-13
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Rhinorrhoea — Feeling: Good · Site: Pain · Sleepiness, Irritability/crying

MedDRA releases: 2024-11
2023-05-14
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair · Site: Pain · Irritability/crying

MedDRA releases: 2024-11
2023-05-15
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair · Irritability/crying

MedDRA releases: 2024-11
2023-05-16
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair

MedDRA releases: 2024-11
2023-05-17
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair

MedDRA releases: 2024-11
2023-05-18
Survey response — days 1–6 daily, dose 3, under 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair

MedDRA releases: 2024-11
2023-05-19
Survey response — day 7, dose 3, under 3
MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Fair

MedDRA releases: 2024-11
2023-05-26
Health check-in — day 14, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-06-02
Health check-in — day 21, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-06-09
Health check-in — day 28, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-06-16
Health check-in — day 35, dose 3, under 3
Feeling: Good

Under 3 check-in
2023-06-23
Survey response — day 42, dose 3, under 3
MedDRA: Dysphonia, Irritability, Respiratory tract congestion — Feeling: Good

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-02-10	Pfizer-BioNTech	Flu:Hib:Pneumonia:Polio:Rotavirus:Tetanus
2	2023-03-10	Pfizer-BioNTech	Flu
3	2023-05-12	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Dysphonia	·	·	✓
SD	Irritability	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SRO	Cough	·	·	✓
SRO	Eye discharge	·	·	✓
SRO	Nasal congestion	·	·	✓
SRO	Rhinorrhoea	·	·	✓
SRO	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release